Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
4
×
boston blog main
boston top stories
clinical trials
boston
cancer
deals
fda
national top stories
san francisco blog main
alexion pharmaceuticals
ally bridge group
amyotrophic lateral sclerosis (als)
autoimmune disorders
avalon ventures
big data analytics
black diamond therapeutics
blackrock
bladder cancer
blueprint medicines
cancer drugs
casdin capital
cetus
chiron
complement system
correlation ventures
deciphera pharmaceuticals
diabetic nephropathy
drugs
eli lilly
endometral cancer
entrepreneurship
europe blog main
european society for medical oncology
eventide asset management
financing
floyd romesberg
focal segmental glomerulosclerosis
What
drug
4
×
lead
4
×
medicines
new
biotech
ipo
raises
advance
alternative
analysis
autoimmune
bio
biologic
biology
black
bring
cancer
candidate
clinic
companies
company
cytokine
deal
demonstrating
develop
diamond
diego’s
disease
diseases
drugs
eluded
employing
enhanced
expensive
genetic
goldfinch
hopes
kidney
later
leading
Language
unset
Current search:
lead
×
drug
×
" national blog main "
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs